New paths in immuno-oncology

The European Medicines Agency has recommended the approval of our immuno-oncology therapy for an aggressive skin cancer.

We look forward to meeting outstanding people with a great attitude, passion, and a restless need to discover the answers to all kinds of questions.

When it comes to making buildings energy-efficient, architects and engineers rely on our materials and technologies.